Integrated Medical Systems, Inc. (IMS) is the leading innovator in the development of fully integrated products for critical care. Our firm, whose principal shareholders include Northrop Grumman Corporation (NGC), is committed to the rapid deployment of products that include portable intensive care systems, advanced diagnostic and therapeutic devices, telemedicine networks, and related information systems. More about IMS
The Center for the Commercialization of Advanced Technologies has awarded IMS a second grant. This grant is to research and develop strategic pricing for its products and services.
Integrated Medical Systems, Inc. (IMS) is the leading innovator in the development of fully integrated products for critical care. Our firm, whose principal shareholders include Northrop Grumman Corporation (NGC), is committed to the rapid deployment of products that include portable intensive care systems, advanced diagnostic and therapeutic devices, telemedicine networks, and related information systems. 
Print
Top of Page